Overview


Nanomedicine is a branch of medicine that uses the tools and knowledge of nanotechnology to treat and prevent various diseases. Boron nitride nanotubes (BNNTs), are a class of innovative, highly intriguing nanomaterials. Boron nitride nut tubes (BNNTs) are an important class of inorganic tubular materials that have received a lot of attention from the nanomedicine community due to their remarkable structural, mechanical, as well as electric properties. BNNTs, which are high-purity and of high quality, are not cytotoxic. Boron nitride nanotubes (BNNT), which have a similar tubular structure to carbon nanotubes (CNT), contain boron and nitrogen molecules arranged in a hexagonal system. BNNT's unique atomic structure gives it many excellent intrinsic properties, including superior mechanical strength, high thermal conductivity, and electrically insulating behavior. It also has the piezoelectric ability, neutron shielding capability, oxidation resistance, and piezoelectricity.

Boron Nitride Nanotubes: Nanomedicine provides all information required by researchers who are interested in this type of smart nanoparticles. An intriguing family of nanomaterials are boron nitride nanotubes (BNNTs). Both in vitro as well as in vivo studies provide evidence for the potential use of BNNTs in biomedical, nanomedicine, and therapeutic applications. These include tissue regeneration, drug delivery, intracellular nano transducers, and nanovectors for drug administration. Boron nitride nanotubes(BNNTs), which have the same tubular structure as carbon nanotubes, are made entirely from boron and nitrogen. They are arranged in a hexagonal lattice. This similarity is evident in both BNNTs and CNT. They share many of the same intrinsic characteristics such as high thermal conductivity, excellent mechanical properties, and high electrical conductivity. The structure of layered boron nitride BN (layered boron) is very similar to graphite. In which boron (B), nitrogen (N), and carbon (C) atoms are substituted, the atoms of boron (N) and boron (N) are removed.

The BNNTs look like a rolled graphite-like sheet of BN, with N and B atoms in place of C. The walls, longitudinal growth, and chirality of BNNTs are the key factors in determining their classification. The walls of BNNTs allow them to be classified as single-walled (SBNNTS), and multi-walled (MBNNTS) BNNTS. However, SBNNTS have been more widely reported in research and applications. Because of the partial ionic nature of the B-N bonds, there are ionic interactions between neighboring layers of BN. This is different from the covalent C–C bonds found in graphene and CNTs. Boron nitride (BNNTs), which have extraordinary mechanical, optical, and electric properties, has attracted a lot of attention in many scientific fields. This makes them more promising as nanomaterials than other nanotubes.

BNNT, regardless of its chirality, is an insulator with a constant wide bandgap. This material has excellent thermal oxidation resistance and piezoelectric properties, as well as high hydrogen adsorption ultraviolet luminescence, cytocompatibility, and stability. As a result of its exceptional properties, BNNT is an ideal material for separation applications, such as membranes. It has been demonstrated that these properties can be used to improve water filtration, gas separation, and sensing. A variety of properties can be enhanced by BNNTs, including flux, rejection, antifouling, sensing, and structural, thermal, and electrical properties. Molecular simulations have been the focus of most research. The literature should therefore be reviewed in its entirety. BNNTs have advanced properties that are discussed in this perspective article. An overview of current literature follows a discussion of how these properties can be used in membrane science.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Boron Nitride nanotubes in Nanomedicine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Boron Nitride nanotubes in Nanomedicine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Amgen Foundation Inc.
  • Astrazeneca
  • Cadila Pharmaceutical industries Ltd
  • Gilead sciences Inc.
  • Novartis AG
  • Pfizer Inc.
  • Celgene Corporation
  • Johnson and Johnson
  • Teva Pharmaceuticals

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Modality

  • Diagnostics
  • Treatments

By Indication

  • Oncological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Orthopedic Disorders
  • Neurological Diseases
  • Urological Diseases
  • Ophthalmological Diseases
  • Immunological Diseases
  • Others

By Application

  • Drug delivery
  • Biomaterials
  • Active Implants
  • Diagnostic Imaging
  • Regenerative Medicine
  • Vaccines
  • Others

By End-User

  • Hospitals and clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Boron Nitride nanotubes in Nanomedicine Market By Modality, By Indication, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Boron Nitride nanotubes in Nanomedicine Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Boron Nitride nanotubes in Nanomedicine Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Boron Nitride nanotubes in Nanomedicine Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Boron Nitride nanotubes in Nanomedicine Market, By Modality Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Diagnostics
        2. Treatments

  • 8.   Boron Nitride nanotubes in Nanomedicine Market, By Indication Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Oncological Diseases
        2. Infectious Diseases
        3. Cardiovascular Diseases
        4. Orthopedic Disorders
        5. Neurological Diseases
        6. Urological Diseases
        7. Ophthalmological Diseases
        8. Immunological Diseases
        9. Others

  • 9.   Boron Nitride nanotubes in Nanomedicine Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Drug delivery
        2. Biomaterials
        3. Active Implants
        4. Diagnostic Imaging
        5. Regenerative Medicine
        6. Vaccines
        7. Others

  • 10.   Boron Nitride nanotubes in Nanomedicine Market, By End-User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals and clinics
        2. Surgical Centers
        3. Diagnostic Centers
        4. Others

  • 11.   North America Boron Nitride nanotubes in Nanomedicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.   Latin America Boron Nitride nanotubes in Nanomedicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.   Europe Boron Nitride nanotubes in Nanomedicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.   Asia Pacific Boron Nitride nanotubes in Nanomedicine Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Amgen Foundation Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Astrazeneca
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cadila Pharmaceutical industries Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Gilead sciences Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Novartis AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pfizer Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Celgene Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Johnson & Johnson
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Teva Pharmaceuticals
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients